to report the 30-day technical and clinical success with endovascular repair using the ultra-low-profile Ovation stent-graft in patients judged out of instruction for use (IFU) for conventional endografts, while amendable to treatment inside the IFU for Ovation (Endologix, Irvine, CA - USA).

Sirignano, P., Mansour, W., Capoccia, L., Cuozzo, S., Camparini, S., de Donato, G., et al. (2019). Immediate results of the expanding indications for treatment with standard EVAR in patients with challenging anatomies, a multi-centric prospective evaluation - EXTREME Study. EUROINTERVENTION [10.4244/EIJ-D-19-00547].

Immediate results of the expanding indications for treatment with standard EVAR in patients with challenging anatomies, a multi-centric prospective evaluation - EXTREME Study

Ippoliti A
2019-01-01

Abstract

to report the 30-day technical and clinical success with endovascular repair using the ultra-low-profile Ovation stent-graft in patients judged out of instruction for use (IFU) for conventional endografts, while amendable to treatment inside the IFU for Ovation (Endologix, Irvine, CA - USA).
2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/22 - CHIRURGIA VASCOLARE
English
endovascular repair, AAA,
Sirignano, P., Mansour, W., Capoccia, L., Cuozzo, S., Camparini, S., de Donato, G., et al. (2019). Immediate results of the expanding indications for treatment with standard EVAR in patients with challenging anatomies, a multi-centric prospective evaluation - EXTREME Study. EUROINTERVENTION [10.4244/EIJ-D-19-00547].
Sirignano, P; Mansour, W; Capoccia, L; Cuozzo, S; Camparini, S; de Donato, G; Mangialardi, N; Ronchey, S; Talarico, F; Setacci, C; Speziale, F; Ippoli...espandi
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/233934
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact